A randomized, double-blind, controlled clinical trial of platelet-rich plasma in the treatment of lateral epicondylitis

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100048591

Enrollment

Unknown

Registered

2021-07-11

Start date

2021-07-12

Completion date

Unknown

Last updated

2022-03-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lateral epicondylitis

Interventions

Control Group:normal saline

Test group:PRP

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Lateral epicondylitis diagnosed by MRI or ultrasound without obvious tendon tear; 2. The course of the disease is greater than 3 months; 3. Ineffective or ineffective after conservative treatment; 4. Recurrent symptoms (>= 2 times).

Exclusion criteria

Exclusion criteria: 1. Newly diagnosed patients who have not undergone any treatment; 2. Has received surgery or PRP treatment and is ineffective; 3. PRP treatment for blood system diseases, infections, coagulation disorders, etc.; 4. Patients are not accepted into the group, and do not accept follow-up plans; 5. Patients with psychiatric symptoms who cannot complete the test and follow-up evaluation.

Design outcomes

Primary

Measure	Time frame
Visual Analogue Scale ;	—

Secondary

Measure	Time frame
Upper Extremity Function Score;daily living ability score;	—

Countries

China

Contacts

Public ContactLiu Yan

West China Hospital, Sichuan University

123315971@qq.com+86 18190030357

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026